MEMSCAP Reports Third-Quarter and Nine-Month 2026 Financial Results

MEMSCAP reported third-quarter 2026 revenue of €3.333 million, up 27.1% year over year, and adjusted EBITDA of €552,000, compared with €346,000 a year earlier. Growth spanned all business segments, led by medical (+80.1%) and aerospace (+22.8%). For the first nine months, revenue rose 17.2% to €10.272 million and adjusted EBITDA totaled €1.502 million. Management cited operating profitability and a sound balance sheet as support for future engine-control and fluidic-systems programs.